JVM to sell fully automated drug inspection machines in US

Hanmi Pharm's subsidiary will sell machines in the US jointly with Euclid Medical Products

JVM's Vizen EX
JVM's Vizen EX
Jung-Eun Kim 1
2023-01-10 11:04:02 likesmile@hankyung.com
Bio & Pharma

Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug dispensing automation machines in the US, on Jan. 2 to sell a fully automated drug inspection machine from its subsidiary JVM. 

According to the company, Euclid is a company located in Ohio and has a drug dispensing automation equipment product line used in pharmacies, hospitals, and nursing facilities. 

JVM's Vizen EX is a product that can inspect up to 400 pills per minute by comparing the quantity, size, and shape of pills with the content of the prescription through a built-in special camera. 

Hanmi Pharm, which is responsible for JVM's overseas business, said that including this partnership, the number of overseas partner firms has increased to 34, and the number of countries in which it has moved in rose to 59. 

"The pharmacist’s most important job, which is as critical as accurate dispensing, is the inspection to prevent mis-administration," said an official of Hanmi Pharmaceutical.

Write to Jung-Eun Kim at likesmile@hankyung.com

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

Rolontis, a neutropenia agent, will be sold in the US under the Rolvedon brand South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has obtained marketing approval from the US Food and Drug Administration.T

KT, Hanmi-invested therapeutics maker Digital Pharm launched

KT, Hanmi-invested therapeutics maker Digital Pharm launched

CEO of Hanmi Pharmaceutical Woo Jong-soo, CEO of Digital Pharm Kim Dae-jin, and vice president of KT Song Jae-ho at the launch of the trilateral business venture on Friday (Courtesy of Hanmi Pharmaceutical) Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an off

Hanmi stands out with own drugs as Korean rivals sell imports

Hanmi stands out with own drugs as Korean rivals sell imports

Hanmi Pharmaceutical’s R&D staff in medication research (Courtesy of Hanmi) South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong demand for its blockbuster high blood pressure drug Amosarta

(* comment hide *}